A MESSAGE TO READERS
NCI Cancer Bulletin Suspends Publication
As of January 8, 2013, the NCI Cancer Bulletin has suspended publication. A searchable archive of more than 5,000 news and feature stories published since 2004 will remain on NCI’s website.
Featured clinical trials and summaries highlighting recent results from cancer clinical trials will continue to be published on cancer.gov. Cancer research news and information are also available through NCI’s social media channels on Twitter, Facebook, and YouTube.
Please feel free to send your comments to ncicancerbulletin@mail.nih.gov.
NEWS
Newly Discovered Gene Linked to Hepatitis C Virus Clearance, Treatment Response
Researchers have identified a genetic variant that is strongly associated with the ability to spontaneously clear infection with the hepatitis C virus (HCV) and with the response to treatment for chronic HCV infection, the leading cause of liver cancer in the United States.
And, in a surprising finding, the discovery of the variant led to the first identification of a previously unknown gene, IFNL4. The variant in this gene is directly responsible for the creation of a newly identified protein, called Interferon Lambda 4 (IFNL4), from the interferon lambda family of proteins. Read more > >
Following Up on Genetic Study, Researchers Identify Potential Therapy for Bladder Cancer
DNA variant may identify candidates for experimental therapyDrug Combination Could Help Treat Deadly Form of Thyroid Cancer
Cell and animal studies also reveal possible molecular target for treating the diseaseTest May Inform Care of Women Infected with HPV
Some HPV-positive women could forgo unnecessary follow-up testsGenetic Mutations Alone Do Not Dictate Cancer Cell Behavior
In the lab, genetically identical tumor cells behaved differentlyAlso in the Journals: Substitute for Drug in Short Supply Found to Be Inferior
Also in the Journals: Video Explains Realities of CPR for Patients with Advanced Cancer
IN DEPTH
U.S. Cancer Deaths Continue Long-Term Decline
Low rates of HPV vaccination cause concern for cancer-prevention efforts
Busting a Myth about How Chemotherapy Works
A growing body of research points to mitochondria
Personal Stories, Evidence Drive Successful Antismoking Ad Campaign
Ads gave voice to millions of people with smoking-related diseases
Featured Clinical Trial: Experimental Drug for Relapsed or Resistant Ovarian Cancer
Will a new targeted drug be effective against advanced gynecologic cancers?
UPDATES
Cancer.gov Update
- New Videos from NCI: "Understanding Your Cancer Prognosis"
Notes
- In Memoriam: Dr. Elwood V. Jensen
- NCI Central Institutional Review Board Receives Accreditation
- Cyber-Seminar: Using State Cancer Profiles for Cancer Control
- Summary of NCI Funding Patterns for FY2012 Available
MULTIMEDIA
NIH Research Radio: Dr. Barry Kramer on Cancer Screening
The director of NCI's Division of Cancer Prevention and editor-in-chief of NCI's Physician Data Query Screening and Prevention Editorial Board talks with NIH Research Radio about cancer screening and the risks that are sometimes associated with it.
Type: (MP3) | Time 8:53 | Size: 10.1 MB | Read Transcipt
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
